Researchers evaluated the efficacy of secukinumab plus a glucocorticoid taper for achieving sustained remission in polymyalgia rheumatica.

Biologics for noninfectious uveitis show safety comparable to conventional systemic therapy when steroid exposure is controlled.

The Food and Drug Administration has approved a new flu vaccine for older people, the first made with the same mRNA ...

The FDA approved mFlusiva, the first mRNA-based influenza vaccine, for adults 50 years and older with accelerated approval for those 65 and older.

A Long Island man’s 2021 illness has been confirmed as New York’s first human Bourbon virus case, highlighting gaps in commercial testing.

Bourbon virus New York: researchers at Stony Brook Medicine confirmed New York State's first human case from a 2021 Long ...

Kidney transplant recipients face severe COVID-19 risks but often are excluded from key antiviral trials. In a target trial ...

From HIV/AIDS to Covid-19, global health emergencies have revived calls for compulsory licensing. But history shows that innovation, technology transfer, and manufacturing capacity—not patent waivers ...

A Cyclospora parasite outbreak has put lettuce in the spotlight as investigators examine a possible link to Taco Bell, raising concerns among consumers about whether it's still safe to eat fresh ...

The Trump administration’s 2026 regulatory agenda quietly published over the long weekend, with plenty of pharma-related items for industry and advocates of various stripes to mull over.

As governments and health authorities rush to meet the moment of a worsening Ebola outbreak in central Africa, Merck & Co. is considering dusting off its antiviral molnupiravir, which saw use as a ...

During the COVID-19 pandemic, antivirals in development pipelines for influenza, Ebola, and other viral threats were rapidly repurposed to treat patients with COVID. One of these antivirals, ...